Search - tctmd.com

Displaying 621 - 640 of 806

Sort: Relevancy | Date

Presentation TCT 2013

Contra Position: Dedicated Bifurcation Stents are a Historical Cconcept and are No Longer Needed!

Presenter: Bernard Chevalier

October 28, 2013

Presentation TCT 2013

Case #2: A Complex Bifurcation: Dedicated Stent, Planned 2 Stents or Provisional Stent strategy?

Presenter: Gregory Pavlides

October 28, 2013

Presentation TCT 2013

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Presenter: Piotr Buszman

October 28, 2013

Presentation TCT 2013

SFA Stents Can No Longer Be Justified on an Outcomes or Cost Basis!

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

Management of Patients with Atrial Fibrillation and Stents

Presenter: Neal Kleiman

October 27, 2013

Presentation TCT 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presenter: Sahil Parikh

October 27, 2013

Presentation

Risk of MACE Following Noncardiac Surgery in Patients with Coronary Stents

Presenter: Mary T. Hawn

October 08, 2013

Presentation Scripps 2013

Complex 3 Vessel Disease and Unprotected Left Main PCI: What Is the Role of Stents in the Post

Presenter: Paul S. Teirstein

October 04, 2013

Presentation Scripps 2013

Drug-eluting Stents 2013: Current Data, Future Advances

Presenter: James B. Hermiller, Jr.

October 03, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

Presentation SOLACI 2013

Can We Still Improve DES Technology?: Newer Bioresorbable Polymer & Polymer-Free Stents

Presenter: Yaron Almagor

July 26, 2013

Presentation SOLACI 2013

Bare-Metal Stents: It Is Impossible to Abandon Them!

Presenter: Conrad Simpfendorfer

July 25, 2013

Presentation SOLACI 2013

Will Polymeric Metal Stents Survive?

Presenter: Ricardo A. Costa

July 25, 2013

Presentation SOLACI 2013

Mechanical Bifurcation Reconstruction with Self-Expanding Stents Versus Metal Distortion with Provisional Stenting and Double Stenting Techniques

Presenter: John Shulze

July 24, 2013

Presentation

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Presenter: Johannes Lammer

July 16, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

Presentation Fellows 2013

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Advertisement

Contra Position: Dedicated Bifurcation Stents are a Historical Cconcept and are No Longer Needed!

Case #2: A Complex Bifurcation: Dedicated Stent, Planned 2 Stents or Provisional Stent strategy?

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

SFA Stents Can No Longer Be Justified on an Outcomes or Cost Basis!

Management of Patients with Atrial Fibrillation and Stents

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Risk of MACE Following Noncardiac Surgery in Patients with Coronary Stents

Complex 3 Vessel Disease and Unprotected Left Main PCI: What Is the Role of Stents in the Post

Drug-eluting Stents 2013: Current Data, Future Advances

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Can We Still Improve DES Technology?: Newer Bioresorbable Polymer & Polymer-Free Stents

Bare-Metal Stents: It Is Impossible to Abandon Them!

Will Polymeric Metal Stents Survive?

Mechanical Bifurcation Reconstruction with Self-Expanding Stents Versus Metal Distortion with Provisional Stenting and Double Stenting Techniques

Heparin-bonded Covered Stents vs. BMS for Complex Femoro-popliteal Artery Lesions

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Drug-Eluting Stents: Past, Present, and Future

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content